Azaya Therapeutics Inc. plans to sell all the Cytori Therapeutics Inc. shares it owns.

The company will sell 1,173,241 Cytori shares at a proposed maximum aggregate offering price of $1.62 apiece for $1.9 million in proceeds. Cytori will receive no proceeds from the sale.

Cytori previously issued the shares when it acquired certain assets from Azaya Therapeutics.